Kazunori Maebashi

Dr. Kazunori Maebashi has been a Senior Project Manager at Meiji Seika Pharma Co., Ltd., Japan since 2011. He became a researcher at Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd. in 2000. During 1986-2000, he worked for Central Research Laboratories at SSP Co., Ltd., Japan. His experiences range from drug discovery to clinical phases of antibacterial and anti fungal agents. He contributed to research and development of drugs such as tebipenem pivoxil (oral carbapenem), ME1071 (metallo-β-lactamase inhibitor), TS2037 (aminoglycoside) and neticonazole (anti fungal imidazole). Recently, he has promoted ME1111 program, topical antifungal drug development for onychomycosis, as a project manager.